Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and sales of product development services.


TSX:CTX - Post by User

Bullboard Posts
Post by gullible1on Feb 13, 2020 8:52pm
365 Views
Post# 30688842

CTX.to is the best DEEP VALUE stock in Canada!

CTX.to is the best DEEP VALUE stock in Canada!Here we have a stock with a market cap of around $20 million and they have $13 million in cash (also $5 million in debt) and a trailing p/e of around 3 or 4.
The author of THE ACQUIRER'S MULTIPLE (Tobias Carlisle) who is an expert on DEEP VALUE investing, does very extensive stock screening and research on value stocks, and has even lectured at Harvard Business School is on twitter declaring on his ACQUIRER'S MULTIPLE twitter account on February 9, 2020:

The best value stock in the Canada All TSX Screener is CTX.TO on an acquirers multiple of 1.6

The interesting thing is that this company also has all kinds of catalysts that could lead to huge growth. They have been approved by Health Canada for a Cannabis Research License opening the door for streams of revenue from lotions or creams that are cannabinoid infused. They are advancing on their pipeline of products to treat plaque psoriasis (approximately 8 or 9 million people in America alone suffer from psoriasis). They have other existing and potential new streams of revenue as well.

If somebody does not write an article on Seeking Alpha about this company soon, I am going to have to take 15 or 20 hours out of my schedule to really detail what this company has going for itself. It represents both deep value and major growth potential. It is the closest thing to a potential superstock or very huge winner among the hundreds of stocks that I monitor.

There is a gentleman from Ontario who did not one but two great blog entries / articles on Crescita. I really wish he would submit his work as an article on Seeking Alpha. That way, I could just put up my KNOCK LOUDLY SLEEPING IN THE BACK sign and just go back to sleep. If not, I am going to have to spend quite a few hours writing an indepth article about this stock for SeekingAlpha dot com website.
Bullboard Posts